Peptides DB
Research-centric peptide and protocol reference hub

Research library

Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.

2255studies indexed1010with human data129registered trials1946carry a numeric findingLibrarian added 23 studies today
Showing 5 studiesSortNewest indexed ▾
B
grade
Identification of alexamorelin consumption biomarkers using human hepatocyte incubations and high-resolution mass spectrometry.
Alexamorelin · Journal of analytical toxicology · 2025 · Observational · n=10
The study found that alexamorelin undergoes significant hepatic metabolism, with its signal decreasing approximately 150-fold after 3 hours, but the detected metabolite is not specific to alexamorelin consumption.
Alexamorelin signal decreased approximately 150-fold after 3 h.
D
grade
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Alexamorelin · Lancet (London, England) · 2025 · ObservationalTop journal
The Global Burden of Disease Study 2023 shows a 6.1% increase in total global DALYs from 2010 to 2023, while age-standardised rates decreased by 12.6%, indicating significant health improvements despite ongoing challenges.
Total global DALYs grew 6.1% (95% UI 4.0-8.1), from 2.64 billion (2.46-2.86) in 2010 to 2.80 billion (2.57-3.08) in 2023.
B
grade
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.
Alexamorelin · Lancet (London, England) · 2025 · Observational · n=204Top journal
In 2023, global deaths reached 60.1 million, with life expectancy at 76.3 years for females and 71.5 years for males, reflecting significant mortality trends influenced by the COVID-19 pandemic.
60.1 million deaths globally in 2023 (95% UI 59.0-61.1), n=204 countries.
A
grade
Effects of oral nutritional supplement on growth and body composition in malnutrition at risk and malnourished children: MARVEL study, a multi-center randomized controlled trial.
Alexamorelin · European journal of nutrition · 2026 · RCT · Phase 4 · n=159
Oral nutritional supplements combined with dietary counseling showed statistically significant improvements in growth metrics in undernourished children, but the clinical relevance of these findings may be limited.
Weight gain: 0.16 kg (95% CI: 0.04-0.28) after 3 months, n=159.
Showing 5 of 5